Most people think success in the hospital means staying until everything is perfect.
Dr. Jeremiah Bearss sees it differently.
From the moment a patient is admitted, one of his primary goals is figuring out how to get them safely back home.
Medicine generates more data than ever before.
But according to Dr. Amogh Havanur, the person sitting in front of you should always matter more than a number on a chart.
The best clinicians know when to trust both.
π§ Watch or listen now: https://t.co/LJuKclnZTi
In this episode of the Good Medicine Podcast, Dr. Jeremiah Bearss and Dr. Amogh Havanur discuss patient-centered care, unnecessary interventions, and why clinical judgment remains essential in modern medicine.
π§ Episode drops tomorrow.
Too much sunlight carries risk.
But too little may also come with consequences.
Dr. David Bearss explains why finding your own balance between sunlight exposure and protection is important for long-term health.
Watch the full episode now β https://t.co/LJuKclnZTi
Sunlight affects more than your skin.
Dr. David Bearss explains how sunlight exposure is tied to serotonin levels and why reduced exposure is linked to seasonal affective disorder.
Your body expects sunlight.
π§ Watch or listen now: https://t.co/LJuKclnZTi
Researchers found women who avoided sunlight had roughly double the all-cause mortality risk.
In low sunlight environments, the increased risk was compared to smoking.
That completely changes how we should think about sun exposure.
π§ Episode drops tomorrow.
Health is not built on one magic pill.
Dr. David Bearss explains why exercise, diet, and sleep remain the three biggest drivers of long-term health and why people need to take ownership of those habits themselves.
Watch the full episode now β https://t.co/LJuKclnZTi
Just one night of poor sleep can disrupt insulin regulation.
That increases risk for cardiovascular disease, obesity, and diabetes.
Sleep is not just about feeling tired the next day. It changes how your body functions.
π§ Watch or listen now: https://t.co/LJuKclnZTi
Dr. David Bearss explains why they are exploring therapies that signal exercise pathways in the body and how AMPK could play a role in the future of metabolic health.
Watch the full episode now β https://t.co/LJuKclnZTi
Most people regain weight after stopping GLP-1s.
But as Dr. Jeremiah Bearss explains, what comes back is often more fat than muscle, which can leave people with worse body composition over time.
π§ Watch or listen now: https://t.co/LJuKclnZTi
The best thing you can do while losing weight is exercise
But according to Dr. David Bearss, one of the biggest downsides of GLP-1 drugs is that many people feel too lousy to actually work out while taking them
That creates a major problem long term
π§ Episode drops tomorrow
Dr. David Bearss explains why better testing systems could fundamentally change the future of medicine by reducing cost, speeding up development, and improving success rates.
Watch the full episode now β https://t.co/LJuKclnZTi
The average drug takes 15 years to reach approval.
A huge portion of that time is spent testing in model systems that often fail to predict what happens in humans.
π§ Watch or listen now: https://t.co/LJuKclnZTi
95% of therapies that work in mice fail in people.
That raises a difficult question:
Are we spending billions of dollars testing drugs in systems that are not actually predictive of human biology?
π§ Episode drops tomorrow.
Cancer diagnosed before 50 doesnβt suddenly appear at 50.
Itβs been developing for years, sometimes decades.
Which means the real question becomes:
What are we exposing kids to today that could be setting this in motion early?
Colon cancer is now the leading cause of cancer death in men under 50β¦ and second in women.
When a disease starts moving up the list this quickly, itβs usually a signal that something bigger is happening beneath the surface.
π§ Watch or listen now: https://t.co/LJuKclnZTi
If you were born in the 90s, your risk of colon cancer is 4x higher than previous generations.
Thatβs not a small trend. Thatβs a massive shift in a very short period of time.
π§ Episode drops tomorrow.
Pharma is facing a massive revenue gap.
With hundreds of billions at risk from patent expirations, companies are looking for new ways to replace that value, and global partnerships are becoming part of the strategy.
Watch the full episode now β https://t.co/LJuKclnZTi
U.S. biotech companies are competing in a system they did not design.
Dr. David Bearss breaks down how companies in China are able to move faster and more efficiently, and why that creates real pressure globally.
π§ Watch or listen now: https://t.co/LJuKclnZTi
Half of major biotech deals are no longer centered in the U.S.
Dr. David Bearss explains how quickly the industry has shifted and what that could mean if the trend continues.
π§ Episode drops tomorrow.